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BACKGROUND: Malaria in pregnancy is of public health 
significance because of its associated maternal and fetal 
complications. This study aimed to assess health workers’ 
awareness and knowledge of the current World Health 
Organisation (WHO) recommendation of intermittent preventive 
treatment in pregnancy with Sulfadoxine-Pyrimethamine (IPTp-
SP). 
METHODS: A cross-sectional study among 148 health workers 
who offer obstetrics care in selected health facilities in Ibadan, 
Nigeria using a self-administered questionnaire to evaluate their 
awareness and knowledge of the current WHO IPTp-SP. 
Information on their socio-demographic and professional 
characteristics, awareness, knowledge and practice of the current 
IPTp recommendation were obtained. Data analysis involved 
descriptive and bivariate analyses using SPSS version 20.0 with 
level of significance set at p<0.05. 
RESULTS: The majority, 85(57.4%), of the health workers had 
been providing obstetrics care for less than 5 years with most of 
them, 114(77.0%), practicing at tertiary health facility. More than 
half, 92(62.2%), of them were aware of the current WHO IPTp-SP 
recommendation while about two-fifth (39.1%) had its correct 
knowledge. Of the health workers who were knowledgeable of the 
current IPTp-SP recommendation almost three-quarter, 29(72.2%) 
of them prescribed it. The health workers’ professional cadre 
(p<0.001) and duration of providing obstetrics care (p=0.012) were 
significantly associated with their awareness and correct 
knowledge of the current IPTp-SP recommendation.  
CONCLUSION: Most of the health workers are aware but not 
knowledgeable of the correct administration of the current IPTp-
SP recommendation. Likewise, many of them do not prescribe it. 
This calls for regular training and update of health workers and 
institutional protocol so as to effectively reduce the prevalence of 
malaria in pregnancy and its complications. 
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INTRODUCTION   
The World Health Organisation (WHO), in 2017, 
reported an estimate of 219 million cases of 
malaria worldwide, compared with 217 million 
cases in 2016 with majority (92%) of the cases 
occurring in WHO African Region (1). Of the 
fifteen countries in sub-Saharan Africa with almost 
80% of the global malaria burden, 5 countries 
accounted for nearly half of all the malaria cases: 
Nigeria with 25% tops the list followed by 
Democratic Republic of the Congo (11%), 
Mozambique (5%), India (4%) and Uganda (4%). 
The 10 highest burden countries in Africa reported 
increase in cases of malaria in 2017 compared with 
2016. Of these, Nigeria, Madagascar and 
Democratic Republic of the Congo had the highest 
estimated increases, all greater than half a million 
cases	(1).		
In	Nigeria,	97%	of	the	populations are at risk 
with pregnant women having 4 times higher 
increased risk due to changes in their hormone 
levels with reduction in immunity to malaria and 
the physiological changes of increased blood flow 
to the skin which promote attractiveness to 
mosquitoes (2,3). The relatively high prevalence of 
19.7% to 72.0% malaria in pregnancy (MiP) is 
attributed to inadequate and/or ineffective 
preventive measures, poor knowledge of risks 
associated with self-medication, negative cultural 
beliefs, and co-infection of intestinal parasites (2,4-
6). The national uptake of intermittent preventive 
treatment with sulfadoxine-pyrimethamine (IPTp-
SP) which is the periodic administration of curative 
dose of an antimalarial drug–SP to pregnant 
women as a preventive measure is low. Although 
this was scaled up from 5 to 15% from 2008 to 
2013 (7-8), the improvement is far below the 80% 
national target (8) and the rate of uptake varying 
from 2% to more than 60% with significant 
regional and socioeconomic disparities in its 
utilisation rates (9).  
MiP is associated with a high rate of maternal 
and perinatal morbidity and mortality including 
maternal and fetal anemia, stillbirth, premature 
delivery and low birth weight (10,11). IPTp-SP at 
scheduled antenatal visits after the first trimester is 
an integral part of the WHO three-branched 
method of preventing and treating malaria during 
pregnancy. This also includes the use of 
Insecticide-Treated Nets (ITNs), and a rapid and 
effective case management. IPTp-SP is beneficial 
in improving pregnancy outcome in malaria 
endemic regions like Nigeria (12-14). 
Prior to 2012, IPTp-SP guideline involved 
administration of at least two doses of SP to 
pregnant women spaced in time at four weeks 
interval and not given at the later stages of 
pregnancy because of the concerns of side effect 
(10). This dosage guideline was updated in October 
2012 by the WHO that at each scheduled antenatal 
clinic (ANC) contact from the second trimester 
(13th week) to the delivery period, IPTp-SP should 
be administered monthly at least four weeks apart 
with a total of 6 doses without safety concerns 
(1,14,15,16). This policy has been adopted since 
2014 (2) but before its adoption, the main strategies 
for the prevention of MiP in Nigeria were by 
chemoprophylaxis using two doses of 
sulphadoxine-pyrimethamine (SP) and use of long-
lasting ITNs (17). Compliance to uptake of IPTp-
SP among pregnant women is influenced by 
several factors. These factors include provider-
client relationship, perceived risk-benefits of the 
drug, previous drug experiences, drug shortages, 
lack of portable water where directly observed 
therapy (DOT) is practiced, and drugs not being 
offered by the health workers (18-20). 
Additionally, studies have shown that health 
workers prescribe un-recommended anti-malaria 
drugs or give wrong dose of SP due to poor 
knowledge on best practices as a result of 
confusion on the timing of IPTp doses or unclear 
policy (17,21).  Challenges in health institution on 
job supervision by stakeholders to ensure 
compliance with recommended MiP guidelines and 
low confidence on the safety of repeated dose of 
SP also impedes compliance with IPTp-SP (22). It 
is therefore against this finding that this present 
study aimed at assessing the awareness and 
knowledge of the current WHO recommendation of 
IPTp-SP among health workers in a South-western 
state in Nigeria four years after it was adopted. 
 
MATERIALS AND METHODS 
  
This was a 4-month cross-sectional study 
conducted from 1st February to 31st May 2018 
among 148 consenting health workers providing 
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daily obstetrics care during antenatal period in 
Adeoyo Maternity Hospital (AMH) and University 
College Hospital (UCH), Ibadan, Oyo state, South 
western Nigeria. Ibadan is the largest city in West 
Africa by geographical area and the 3rd largest city 
in Nigeria with a population of over 3.5 million. 
Prevalence of malaria in pregnancy in this region is 
about 4.8-7.7% between 2011 and 2019 (23).  
The Ibadan North local government area 
(LGA) was purposively selected from the 11 LGAs 
in Ibadan because it is the only LGA with a tertiary 
health facility and AMH was randomly selected 
from the 5 secondary health facilities in the LGA. 
UCH, the premier teaching hospital in Nigeria, has 
an average of 8,300 and 1,700 pregnant women 
attending antenatal and booking clinic yearly while 
13,000 and 4,200 attend AMH respectively. 
The sample size of 116 was computed with 
WinPepi version 11.65 using confidence level of 
95 % and assuming a minimum of 50 % of health 
workers would be knowledgeable about the current 
WHO IPTp-SP with the total population of eligible 
health workers taken into consideration. All 
consenting health workers providing antenatal care 
services in the antenatal clinics and wards of the 
two hospitals during the study period were 
interviewed using a self-administered semi-
structured paper-based questionnaire designed by 
the investigators and pre-tested to assess for clarity 
and understanding of the questions and validation 
prior to its administration. 
Information on their socio-demographics and 
professional characteristics, awareness and 
knowledge of the current WHO IPTp-SP 
recommendation and practice, and reasons for non-
adherence	 to the recommendation were obtained. 
Ethical approval was obtained from the Oyo state 
ethics review committee and a written informed 
consent was obtained from the respondent before 
administration of the questionnaire by trained 
research assistant. Health workers that were neither 
nurses nor doctors and those not providing 
antenatal care services were excluded from the 
study. 
In this study, awareness of the current WHO 
IPTp-SP was defined as “respondent having heard 
of the use of monthly IPTp-SP from second 
trimester to the delivery period adopted in Nigeria 
in 2014” while full knowledge of all the 
components of the current WHO IPTp-SP which 
includes “ability to appropriately identify the 
gestational age (from the beginning of the 13th 
week or second trimester) to commence the IPTp-
SP, the dose (500 mg Sulphadoxine and 25 mg 
Pyrimethamine per tablet with three tablets given 
as one full dose), the frequency (monthly - at least 
four weeks apart), and the use of IPTp-SP not 
restricted till delivery period (when to discontinue 
the use of IPTp-SP in late pregnancy)”was  
categorized as correct knowledge. The practice of 
the current WHO IPTp-SP recommendation by the 
health workers was assessed by self-report of its 
recommendation/prescription and the actions taken 
(information given to the pregnant women and its 
documentation in the case note).  In addition, the 
knowledge of the previous WHO recommendation 
on IPTp-SP dosing, timing and frequency was 
assessed.  
Data was cleaned, entered and analysed using 
IBM SPSS version 20.0. Continuous variables were 
expressed as mean and standard deviation and 
categorical variables as percentage. The Chi-square 
test was used to identify the factors associated with 
respondents’ awareness and knowledge of current 
WHO recommendation of IPTp-SP, and the level 




Of the 148 health workers studied, the majority, 
114(77.0%,) were nurses/midwives while 23.0% 
were doctors of which 6.1% were resident doctors 
undergoing specialist training in obstetrics and 
gynaecology. A little above half, 85(57.4%), had 
been providing obstetrics care during the antenatal 
period for less than 5 years while the majority, 
114(77.0%), practiced at the tertiary level of health 
care. On the average, more than half, 84(56.8%), of 
the health workers attended to about 16 pregnant 
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Table1: Baseline characteristics of respondents 
 





















































Almost all, 140(94.6%), the health workers had 
knowledge of the previous WHO recommendation 
of 2 doses of IPT with SP for MiP at four weeks 
interval, and 123(83.1%) knew the correct time for 
the commencement of its administration while only 
46(31.1%) had knowledge of required additional 
dose of IPTp-SP in some medical conditions like  
sickle cell disease and human immunodeficiency 
virus positive women (Table 2).
  
Table 2: Knowledge of Sulphadoxine-Pyrimethamine (SP) for IPT of Malaria in Pregnancy (previous 
recommendation of 2 doses in pregnancy) 
Variable Frequency  Percentage  









Knowledge of onset of administration time for IPTp 
























Regarding the current WHO recommendation of 
IPTp-SP, about two-third (62.2%) of the health 
workers were aware of it while only 36(39.1%) of 
them had the correct knowledge of its 
administration. The majority (72.2%) of the health 
workers who had correct knowledge of the current 
WHO IPTp-SP recommendation prescribed it. 
However, of the general study population, the 
majority, 133(89.9%), endorsed adoption of the 
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Table 3: Awareness and knowledge of current WHO IPTp-SP recommendation 
 
Variable  Frequency  Percentage  

















































The health workers who were aware, 
knowledgeable and prescribed the current WHO 
IPTp-SP recommendation took some actions 
during the routine prescription. These actions 
include	 informing the women on the reason for 
IPTp, when to take the next dose, the adverse 
reactions that could occur and to report back if 
adverse reaction(s) occurs in addition to 
documenting the prescribed drug in the case note 










0 20 40 60 80 100 120
Document the prescribed drug in casenote
Inform the women to present at the hospital if reaction
occurs
Inform the pregnant women on the adverse reactions to
the IPTp
Inform the pregnant women on the next dose of  IPTp
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Figure 2: Reasons for non-adherence to current WHO IPTp-SP recommendation (multiple responses 
among health workers who do not prescribe the current recommendation). 
 
In addition, the health workers who were 
knowledgeable and prescribed the currently 
recommended WHO IPTp-SP over the previous 
recommendation do so because it has fewer side 
effects (46.8%), more effective (37.6%), more 
benefits (31.4%) and for the reason that it is 
recommended by WHO (18.8%). However, over a 
third (37.5%) of the health workers who were 
knowledgeable of the current IPTp-SP 
recommendation did not prescribe it, because it 
was not part of their hospital protocol while 23.6% 
and 8.3% had the fear that repeated doses is 
associated with side effects and resistance to SP 
respectively (Figure 2).  
A higher proportion of doctors were aware 
and had correct knowledge of the current WHO 
IPTp-SP recommendation (80.0%) compared to 
nurses/midwives (22.4%), (p<0.001). Also, the 
majority of the health workers who had provided 
antenatal obstetric care for less than five years were 
aware and had correct knowledge of the current 
WHO IPTp-SP recommendations compared to 
those who had practiced for five years and more, 
(p=0.012). These were statistically significant at 
p<0.001 and 0.012 respectively. Although not 
significant, health workers practicing at secondary 
health facility were aware and had correct 
knowledge of the current WHO IPTp-SP 
recommendations compared to those practicing at 




The awareness of the current WHO IPTp-SP 
among the health workers in this study is relatively 
high while only few of them had the correct 
knowledge and prescribed it.  The finding of low 
proportion of health workers having the correct 
knowledge of the current WHO recommendation of 
IPTp-SP corroborates the report from other studies 
(18,22,24,25). Most studies in sub-Saharan Africa 
including Nigeria documented that health workers’ 
inadequate knowledge as key barrier to 
recommendation of IPTp in both private and public 
health facilities (22,24-26). Likewise, in a 
systematic review and meta-analysis of the factors 
affecting the delivery, access, and use of 
interventions to prevent MiP, poor knowledge and 
poor administration of IPTp guidelines by health 
workers were identified as the most significant 
barriers to achieving high coverage of IPTp (18).  
This poor knowledge and practices of IPTp-SP in 
MiP was similarly reported in Ibadan as far back as 
2012 among health workers (21). This trend could 
depict that the health workers lack enough 
information, are inadequately trained or unclear of 
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I am not aware it can be given monthly
It is not recommended
Fear of resistant to SP
Not part of institution protocol
Do not believe it is more beneficial
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Table 4: Association between awareness and correct knowledge of the current WHO SP for IPTp and 
selected baseline characteristics of the respondents. 
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Almost three quarters (62.2%) of the respondents 
were aware of the current IPTp-SP recommendation, 
but only a few of them recommend in pregnancy. 
This could probably be attributed to their incorrect 
knowledge, inability to recall the specifics of the 
recommendation, different hospital protocol or use of 
trade names and tablet dosing rather than generic 
names and strengths of drugs (27). Also, confusion 
among health workers on the timing and dosing of 
IPTp with SP administration has been identified as 
the main barrier slowing the efforts to scale-up IPTp-
SP in Africa (28). These findings underscore the need 
to create more awareness and improve specific 
knowledge on IPTp-SP among frontline health 
workers that provides antenatal care through training 
and provision of the current WHO IPTp policy and 
simplified guideline to improve their practice of 
delivering IPTp.   
As shown in this study, the main actions by the 
health workers who are aware, knowledgeable and 
prescribed the current recommended IPTp-SP during 
routine administration ranged from informing the 
pregnant women on the reason for the IPTp, when to 
take the next dose and documentation of the 
prescribed drug in the case note. This implies that 
these health workers are knowledgeable of the 
expected practices during routine IPTp administration 
(29). 
Furthermore, the main reason given by the health 
workers who were knowledgeable but were non-
adherence to prescribing the current recommendation 
was that the IPTp-SP recommendation was not in 
their institutional protocol. Other reasons were side 
effects of repeated use of IPTp-SP, not believing it is 
more beneficial than the previous recommendation of 
2 doses and the fear of resistant to SP. Some of these 
reasons were like those reported by other researchers 
in malaria endemic regions regarding the earlier 
recommendation guideline (30,31). This can be 
narrowed down to their inadequate knowledge of the 
details of the current guideline. Therefore, 
considering these reasons, there is a need for the 
ministry of health to assess the use of the current 
WHO recommendation of IPTp in health facilities, 
and if need be, to disseminate this updated 
recommendation widely so as to improve its correct 
prescription and thus its effectiveness in preventing 
MiP with its resultant maternal and fetal 
complications. Furthermore, the use of mobile health 
in complementing classroom training on IPTp which 
has been shown to significantly improve health 
workers’ knowledge and performance in adhering to 
guidelines and scaling up of IPTp can be adopted 
(32).  
Additionally, health workers with the knowledge 
of the current IPTp recommendation who also 
prescribe it do so because it is recommended by 
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WHO, more beneficial and more effective. This 
buttress reports from other studies among health 
workers with similar explanations given as reasons 
for their compliance in prescribing the recommended 
drugs for malaria prophylactics at the required dose 
and time (33,34). Knowledge accrued from trainings 
or other sources might also contribute a great deal. It 
is recommended that health workers especially those 
providing antenatal obstetric care be trained on the 
current recommendation of IPTp-SP in order to 
effectively prescribe it. This could be corroborated 
with Arulogun et al’s report in which health workers’ 
main source of IPTp knowledge was through training 
(21). 
Factors significantly associated with health 
workers’ awareness and correct knowledge of the 
current WHO IPTp-SP recommendation were 
professional cadre and duration of practice of 
antenatal obstetric care. The doctors in our study were 
more aware and had correct knowledge of the current 
recommendation than the nurses/midwives. This 
substantiates Ng’etich et al report from Kenya on 
providers’ knowledge of the guidelines for IPT for 
MiP with most clinical officers being knowledgeable 
about current WHO IPTp -SP compared with the 
other professional cadres (35). However, it 
contradicts the report of the survey conducted by 
Maheu-Giroux and Castro on factors affecting 
providers’ delivery of IPTp, in which clinicians were 
least likely to deliver IPTp to their clients (36). This 
might also be because our study was conducted in a 
secondary and tertiary institution which are referral 
hospitals where high risk pregnancies are managed. 
Accordingly, doctors/clinicians attend to women with 
high risk pregnancy at clinic visit/contact, so they are 
at the forefront of prescribing IPTp compared to 
primary health facilities where nurse/midwives, 
community health extension workers and community 
health officers attend to low risk pregnant women 
(37).  
Our study showed that health workers providing 
antenatal obstetrics care for less than five years were 
more aware and had correct knowledge of WHO 
IPTp-SP than their colleagues who had been 
practicing for more than five years.  The probable 
explanation to this is that these set of health workers 
having less than five years’ experience in obstetrics 
might have received adequate training about the new 
recommendation prior to commencement of work in 
ANC of these health facilities. This finding was not in 
keeping with previous report on providers’ 
knowledge of the guidelines for IPT for MiP as the 
providers with less than 5 years of professional 
experience were less knowledgeable about the current 
IPTp recommendation in Kenya, though the 
association was not found to be statistically 
significant on further analysis (35). 
Our study has its own limitations. No variable in 
the questionnaire assessed if the health workers had 
recent trainings or workshop and the source of 
information on the current WHO IPTp-SP among 
those that were knowledgeable. This could have 
formed a basis for dissemination of updated 
information on malaria chemoprophylaxis in 
pregnancy to the health workers. Also, their attitude 
and constraints were not assessed as this would have 
given further information for their non-adherence to 
the current recommendation. In addition, adherence to 
DOT, contraindications to IPTp-SP and health 
workers who prescribe based on only the number of 
tablets/pills to be taken rather than exact dosage and 
strength was not explored. Conversely, to the best of 
our knowledge, this is the first study that assessed the 
health workers’ awareness, knowledge and practice of 
the current WHO recommendation of IPTp-SP in our 
environment, and the study provides a sample of 
health workers in one of the 774 LGAs in Nigeria. 
Though the study cannot be generalized. It will serve 
as a basis for further studies in other geopolitical 
zones and among health workers in private and 
primary health facilities.  
However, it is important that institutional 
guidelines are reviewed and updated with the use of 
evidence-based practice to include the current 
recommendation for IPTp-SP. Periodical training on 
current recommendation should also be organised to 
upgrade the knowledge of health professionals 
attending to pregnant women during scheduled 
antenatal visits.  
In conclusion, the knowledge and correct 
administration of the current WHO recommendation 
of IPTp-SP among health workers is inadequate. 
Though a higher proportion among the few ones with 
correct knowledge prescribes it according to 
specification of the WHO guideline recommendation, 
adherence to current WHO IPTp-SP should be 
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